Roche's head of research retires
This article was originally published in Scrip
Executive Summary
Professor Jonathan Knowles is to retire as Roche's head of group research and from the company's corporate executive committee at the end of next year. He will hand over his responsibilities to Lee Babiss, head of pharma research, and Jean-Jacques Garaud, head of pharma development. Professor Knowles will remain a member of Roche's executive committee, its pharma strategic portfolio committee, and a member of Genentechand Chugai's boards. He joined Roche in 1997 as head of global pharma research and took up his current position in 2006.
You may also be interested in...
Myotec and Hybrid merge to form PsiOxus
Myotec Therapeutics and Hybrid Biosystems are to merge to form PsiOxus Therapeutics with £3.6 million in funding from a syndicate led by the former's previous backer Imperial Innovations.
Trophos's MitoCare programme receives €6 million EU funding
A Phase II efficacy and safety study of Trophos' cholesterol-oxime compound TRO40303 to treat cardiac ischaemia-reperfusion injury in acute myocardial infarction patients will be substantially underwritten by funds from the European Union, the Marseilles-based company says. Trophos is to head a new 16-partner consortium called MitoCare, a 2.5 year international translational medicine project that has received a €6 million award under the European Union Seventh Framework Programme for research. The project will begin in January 2011.
Novartis and Alcon reach compromise to settle merger saga
Alcon's board of directors has finally approved a merger agreement with Novartis for the Alcon shares the latter does not already own, drawing a close to protracted negotiations that first began nearly a year ago.